Newsletter Subject

Measles' Deadliest Sequelae

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Mar 2, 2024 12:16 PM

Email Preheader Text

Weekly Review Saturday, March 02, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT [Ev

[MEDPAGE TODAY]( Weekly Review Saturday, March 02, 2024 [Measles' Deadliest Sequelae]( [CDC Shortens COVID Isolation Recs]( [Trump, Biden, and Cognition]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Individualizing Advanced/Metastatic HER2+ Breast Cancer Care: Evidence-Based and Patient-Centered Approaches]( [Older Adults Should Get Another COVID Booster, CDC Advisors Say]( [The Misleading Headlines Behind the New COVID Vaccine Safety Study]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Even Modest Lp(a) Elevations Bode Poorly for Cardiovascular Health]( CME SPOTLIGHT [Expert Insights and System-Based Care Trends in Early-Stage NSCLC and Melanoma, Metastatic Bladder Cancer, and Relapsed/Refractory Follicular Lymphoma]( [Cannabis Singled Out for Cardiovascular Risk]( [Oregon Pathologist Reportedly Missed Cancer Diagnoses]( [Doctor Mistakenly Accused of Shouting Racist Slurs at Woman]( CME SPOTLIGHT [Expert Insights and System-Based Care Trends in Early-Stage NSCLC and Melanoma, Metastatic Bladder Cancer, and Relapsed/Refractory Follicular Lymphoma]( [Take Your Supplements With a Big Grain of Salt]( [Sinusitis Tied to Later Autoimmune Disease]( [Doctor's Family Sues Disney Over Food Allergy Death; Doctor Skipped Payroll Taxes?]( CME SPOTLIGHT [Latest Clinical Evidence in Adult Diffuse Low-Grade Glioma]( [FDA Authorized Florida's Drug Importation Plan. Naysayers Are Balking.]( [Leaky Blood Vessels and Long COVID; BCG Vaccine and Alzheimer's; New CTE Subtype]( [CDC Monitoring Rare Neurologic Events After RSV Vaccination]( CME SPOTLIGHT [Leveraging the Multidisciplinary Team to Improve Lung Cancer Care]( [Why Discarding Embryos Is Inherent to the IVF Process]( [SNAP Benefits and BP Meds; Post-PCI Anticoagulation Flop; CPAP's Potential Harm]( [CAR-T for Autoimmune Disease; Methods of Illegal Opioid Overdose]( CME SPOTLIGHT [PARP Prodigy: Mastering Metastatic Castration-Resistant Prostate Cancer]( [NYC Medical School Goes Tuition-Free Thanks to $1 Billion Gift]( [FDA Announces End to 'Forever Chemicals' in U.S. Food Packaging]( [My Go-To Strategies for Making Alliances With Angry Patients]( CME SPOTLIGHT [Integrating Biomarkers and Guideline-Aligned Treatment Approaches Into Patient-Centered Care for Advanced/Metastatic Endometrial Cancer]( ['This Is an Extremely Rare Phenomenon': What We Heard This Week]( [Measurable Cognitive Deficits Linked to Long COVID]( [MedPod Today: Are MA 'Extras' Used? USMLE Cheating Scandal; Keto for Mental Health]( CME SPOTLIGHT [Emerging Clinical Efficacy and Safety Data in Recurrent and Metastatic Cervical Cancer]( [Three Tools to Address Health Equity]( [Unmasking a Nurse's Journey Through Long COVID Gaslighting]( [Healthy Lifestyle Habits May Help Prevent New-Onset IBS]( [Health Workers Push for Their Own Confidential Mental Health Treatment]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-03-02&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.